Neil W Gibson Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Neil W Gibson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Neil W Gibson. Neil W Gibson is a Chief Scientific Officer in Regulus Therapeutics Inc. ($RGLS) and a Director in Shattuck Labs, Inc. ($STTK) and a Director in TCR2 THERAPEUTICS INC. ($TCRR) and a Director in Instil Bio, Inc. ($TIL).
Address: C/O REGULUS THERAPEUTICS INC. 3545 JOHN HOPKINS COURT, SUITE 210 SAN DIEGO 92121 CA
Companies in which Neil W Gibson is an Insider
Instil Bio, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Neil W Gibson: Director
Holdings: 0 shares
Latest Transaction: Mar 22 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Regulus Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Neil W Gibson: Chief Scientific Officer
Holdings: 80,000 shares
Current Value: $112,000
Latest Transaction: Jun 18 2014
$RGLS Market Capitalization: $72.77M
$RGLS Previous Close: $1.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Shattuck Labs, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Neil W Gibson: Director
Holdings: 0 shares
Latest Transaction: Dec 28 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TCR2 THERAPEUTICS INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Neil W Gibson: Director
Holdings: 493,791 shares
Latest Transaction: Dec 11 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Neil W Gibson
Sentiment: All, TIL, RGLS, STTK, TCRR
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 22 2021 | TIL | Instil Bio, Inc. | Gibson Neil W | Director | Option Exercise | A | 20.00 | 52,000 | 1,040,000 | 52,000 | |
| Dec 28 2020 | STTK | Shattuck Labs, Inc ... | Gibson Neil W | Director | Option Exercise | A | 53.02 | 1,286 | 68,184 | 1,286 | |
| Dec 11 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Option Exercise | A | 31.83 | 12,100 | 385,143 | 12,100 | |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | S | 7.94 | 648 | 5,145 | 0 | 648 to 0 (-100.00 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | S | 7.41 | 3,140 | 23,267 | 648 | 3.8 K to 648 (-82.89 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | S | 6.83 | 3,120 | 21,310 | 3,788 | 6.9 K to 3.8 K (-45.17 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | S | 6.49 | 3,009 | 19,528 | 6,908 | 9.9 K to 6.9 K (-30.34 %) |